 Hypogonadal impotence transdermal testosterone transdermal therapeutic system testosterone TTS-T ALZA scrotal skin twenty-two hours twelve weeks men hypogonadal impotence men TTS-T long twenty-six months system daily dose S.E mg nominal dose mg system dose mg nominal dose mg systems serum testosterone dihydrotestosterone DHT physiologic levels normal erectile activity increased frequency ejaculation positive effect mood energy changes serum sex globulin estradiol prostate breast size hematologic liver function measures urinary flow frequency significant changes serum cholesterol low-density lipoproteins high-density lipoproteins dermatologic problems system tenfold increase DHT baseline levels reduction testosterone scrotal skin TTS-T convenient reliable mimics normal physiologic testosterone secretion levels conventional methods testosterone replacement